5-Thiazolecarboxaldehyde, 2-(4-Methoxyphenyl)-

Designated under Product Code TZ-AL-401 and registered with CAS RN 885278-98-6, 5-thiazolecarboxaldehyde, 2-(4-methoxyphenyl)- (synonym: 2-(4-methoxyphenyl)thiazole-5-carbaldehyde) is supplied as a crystalline solid with a molecular formula of C₁₁H₉NO₂S and a molecular weight of 219.26 g·mol⁻¹. The compound integrates an electron-rich 4-methoxyphenyl ring at the 2-position of a thiazole core bearing a reactive formyl group at the 5-position. Manufacturing is performed in jacketed glass-lined reactors under positive nitrogen pressure, with intermediate purification by fractional crystallization from ethanol/water mixtures and final isolation via vacuum filtration through a 0.2 µm PTFE membrane. The resulting lot sizes, typically 1–5 kg, are homogenized using a V-blender to ensure inter-lot consistency within the certified purity window of ≥98.5% as determined by HPLC (area normalization at 254 nm). The compound serves as a pivotal building block in the synthesis of bioactive thiazole-containing heterocycles, particularly where the methoxy substituent modulates both electronic character and metabolic stability of downstream pharmacophores.

How Does the 4-Methoxyphenyl Substituent Alter Reactivity Compared to Unsubstituted Phenyl Analogs?

Introduction of the para-methoxy group shifts the electron density of the pendant aryl ring by a Hammett substituent constant σ_p of approximately −0.27, rendering the ring significantly more electron-rich than that of 2-phenyl-5-thiazolecarboxaldehyde (σ_p ≈ 0.00). This electronic perturbation has two measurable consequences in downstream chemistry. First, electrophilic aromatic substitution on the existing methoxyphenyl ring proceeds with higher regioselectivity; nitration with HNO₃/H₂SO₄ at 0–5°C yields the meta-nitro derivative in 78% isolated yield versus 52% for the unsubstituted phenyl congener. Second, the electron-donating effect strengthens the aldehyde’s engagement in Knoevenagel condensations with active methylene compounds. In a standardized protocol using ethyl cyanoacetate and piperidine catalyst in ethanol at reflux, the time to reach >95% conversion as tracked by in situ ReactIR is reduced from 4.2 h (2-phenyl analog) to 2.1 h for the 4-methoxyphenyl derivative. This rate acceleration permits lower catalyst loadings—0.05 eq versus the typical 0.10 eq—minimizing amine-related byproducts in scale-up campaigns run in 50 L glass-lined reactors. Comparative data are summarized in Table 2.

Storage-Dependent Degradation Thresholds and Inert Atmosphere Requirements

Accelerated stability studies performed at 40°C/75% RH for 6 months have identified two primary degradation pathways: aldehyde autoxidation to the corresponding carboxylic acid, and hydrolytic ring-opening of the thiazole under prolonged moisture exposure. The acid impurity (2-(4-methoxyphenyl)thiazole-5-carboxylic acid) reaches the specification alert limit of 1.5% within 28 days when the compound is stored in polyethylene-lined fiber drums under ambient air. In contrast, the same impurity level under nitrogen blanket (O₂ < 10 ppm) in double LDPE-bagged aluminium foil pouches containing molecular sieve desiccant (3 Å, 10% w/w) is not exceeded for 720 days at 25°C. Consequently, the recommended storage condition is −20°C ± 5°C under argon or nitrogen, with retest dating of 24 months from the date of manufacture when container integrity is maintained. Open-container handling in laboratories should be minimized; aliquoting into pre-dried amber vials within a glovebox preserving <1% RH is advised for long-term building block inventories.

When the Aldehyde Serves as a Key Intermediate in Kinase Inhibitor Synthesis

Process chemistry groups developing Type II kinase inhibitors have adopted TZ-AL-401 as a direct precursor to the 5-aminomethyl-2-(4-methoxyphenyl)thiazole hinge-binding motif. Reductive amination with N-Boc-4-aminopiperidine using sodium triacetoxyborohydride in dichloromethane at 10–15°C proceeds with >90% conversion within 6 h, while the electron-poor 2-(4-nitrophenyl) variant requires 12–16 h under identical stoichiometry and fails to exceed 70% conversion due to competitive reduction of the nitro group. The methoxy analog thus eliminates the need for a pre-installed protected aniline unit, effectively shortening the synthetic sequence from 7 to 5 linear steps for a representative clinical candidate (disclosed in WO 2021/119098). In pilot-plant batches conducted in a 100 L Hastelloy reactor with retreat-curve impeller agitation at 150 rpm, the isolated Boc-protected secondary amine hydrochloride salt exhibits chemical purity exceeding 99.2% following a single reslurry in methyl tert-butyl ether, without recourse to chromatographic purification. This contrasts with the uncontrolled gumming observed during workup when using the unsubstituted phenylthiazole aldehyde, a phenomenon attributed to the lower polarity of that benzylamine intermediate.

A distinct utility profile emerges in the preparation of thiazole-based organic semiconductors for solution-processed field-effect transistors. Condensation of TZ-AL-401 with 2,2′-(2,5-bis(hexyloxy)-1,4-phenylene)diacetonitrile in the presence of potassium tert-butoxide in THF yields a donor–acceptor oligomer with an optical bandgap of 2.18 eV (as measured by UV-Vis onset in thin film) and a HOMO level of −5.32 eV determined by photoelectron spectroscopy in air (PESA). The corresponding oligomer derived from 2-(4-cyanophenyl)thiazole-5-carboxaldehyde exhibits a HOMO of −5.61 eV, resulting in a hole injection barrier with PEDOT:PSS electrodes (Φ = 5.1 eV) that is 0.51 eV higher, thereby degrading saturation mobility in top-gate bottom-contact devices from 0.12 cm²·V⁻¹·s⁻¹ to 0.02 cm²·V⁻¹·s⁻¹. The methoxy substituent’s electron-donating capacity, quantified by a Swain-Lupton field parameter F of 0.29 and resonance parameter R of −0.56, is essential to maintaining coincidence between the polymer ionization energy and the electrode work function without resorting to interfacial self-assembled monolayers that complicate slot-die coating processes.

Batch-to-Batch Consistency and Equipment-Dependent Variability

Across 42 consecutive commercial batches manufactured over 18 months, the mean HPLC purity was 99.05% with a standard deviation of 0.28%. The single out-of-specification batch (97.8%) was traced to a vacuum pump malfunction during crystallization that permitted residual ethanol to rise to 1.2% w/w, promoting solvolysis of the thiazole ring. Implementation of an online residual gas analyzer (MKS Instruments Cirrus 3) on the vacuum distillation line now provides early detection at ≤1 Torr aberrations. Customers incorporating TZ-AL-401 into GMP intermediate supply chains must further note that milling to a particle size D₉₀ < 50 µm using a jet mill (Hosokawa Alpine 50 AS) can reduce the melting endotherm onset by 2–3°C due to amorphous content generation, detectable by modulated DSC. This physical change has no impact on solution-phase reactions but must be disclosed in the drug master file if the aldehyde is charged as a solid in a heterogeneous system.

Requested industrial documentation includes REACH registration compliance for imported quantities below 1 tonne/annum (substance classified as reportable intermediate under strictly controlled conditions per Article 17/18). The certificate of analysis for each batch references the ISO 17025-accredited subcontractor for heavy metals unless its concentration is below the reporting limit. A safety data sheet aligned with Regulation (EC) No. 1272/2008 must be consulted; the aldehyde group triggers Skin Sens. 1B classification (H317). Incompatibilities documented in process safety evaluations include rapid exothermic decomposition when combined with concentrated aqueous sodium hydroxide above 60°C, adiabatic Delta T_ad estimated at 180°C by ARSST calorimetry, which precludes direct aqueous alkaline aldol protocols unless controlled dosing maintains bulk temperature below 30°C.